Cargando…

Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis

Trimethylamine N-oxide (TMAO) is a biologically active molecule generated by the gut microbiota. Accumulating evidences have indicated a close association between high plasma TMAO levels and the risk of developing atherosclerosis (AS). AS is considered a chronic inflammatory disease initiated by vas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yarong, Dai, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048942/ https://www.ncbi.nlm.nih.gov/pubmed/32148438 http://dx.doi.org/10.1155/2020/4634172

Ejemplares similares

Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
por: Zhu, Yingqian, et al.
Publicado: (2020)

Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation
por: Panyod, Suraphan, et al.
Publicado: (2022)

Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
por: Hoyles, Lesley, et al.
Publicado: (2018)

Gut microbiota dependant trimethylamine N-oxide and hypertension
por: Mutengo, Katongo H., et al.
Publicado: (2023)

Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: Wang, BingYu, et al.
Publicado: (2021)

Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
por: Macpherson, Magnhild E., et al.
Publicado: (2020)

Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide
por: Nam, Hyo Suk
Publicado: (2019)

Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome
por: Li, Xingxing, et al.
Publicado: (2021)

Ginger essential oil and citral ameliorates atherosclerosis in ApoE(−/−) mice by modulating trimethylamine-N-oxide and gut microbiota
por: Panyod, Suraphan, et al.
Publicado: (2023)

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2018)

It's a “Gut Feeling”: Association of Microbiota, Trimethylamine N‐Oxide and Cardiovascular Outcomes
por: Kolluru, Gopi K., et al.
Publicado: (2020)

Elevation of the Gut Microbiota Metabolite Trimethylamine N-Oxide Predicts Stroke Outcome
por: Nam, Hyo Suk, et al.
Publicado: (2019)

Gut microbiota-dependent trimethylamine n-oxide pathway contributes to the bidirectional relationship between intestinal inflammation and periodontitis
por: Wang, Qiqi, et al.
Publicado: (2023)

Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
por: Jing, Lele, et al.
Publicado: (2022)

The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease
por: El Hage, Racha, et al.
Publicado: (2023)

Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension
por: Jiang, Shan, et al.
Publicado: (2021)

Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke
por: Sun, Taoping, et al.
Publicado: (2021)

Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand
por: Senthong, Vichai, et al.
Publicado: (2021)

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
por: Chen, Ming-liang, et al.
Publicado: (2016)

Experimental Periodontitis Deteriorated Atherosclerosis Associated With Trimethylamine N-Oxide Metabolism in Mice
por: Xiao, Lingling, et al.
Publicado: (2022)

Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota
por: Wang, Xin, et al.
Publicado: (2020)

Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-N-Oxide Response in Healthy Men
por: Cho, Clara E., et al.
Publicado: (2020)

Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review
por: Zhang, Peng, et al.
Publicado: (2023)

Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice
por: Wang, Zhichao, et al.
Publicado: (2022)

Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis
por: Zhou, Dengcheng, et al.
Publicado: (2022)

Corrigendum: Experimental Periodontitis Deteriorated Atherosclerosis Associated With Trimethylamine N-Oxide Metabolism in Mice
por: Xiao, Lingling, et al.
Publicado: (2022)

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)

Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
por: Randrianarisoa, Elko, et al.
Publicado: (2016)

Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism
por: Ding, Lin, et al.
Publicado: (2018)

Trimethylamine-N-Oxide Levels Are Similar in Asymptomatic vs. Symptomatic Cerebrovascular Atherosclerosis
por: Heyse, Miriam, et al.
Publicado: (2021)

Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
por: Smits, Loek P., et al.
Publicado: (2018)

Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease
por: He, Wei, et al.
Publicado: (2020)

Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD
por: Al-Obaide, Mohammed A. I., et al.
Publicado: (2017)

Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke
por: Tan, Chuhong, et al.
Publicado: (2020)

β-sitosterol inhibits trimethylamine production by regulating the gut microbiota and attenuates atherosclerosis in ApoE(–/–) mice
por: Wu, Weiping, et al.
Publicado: (2022)

Connections between serum Trimethylamine N-Oxide (TMAO), a gut-derived metabolite, and vascular biomarkers evaluating arterial stiffness and subclinical atherosclerosis in children with obesity
por: Mihuta, Monica Simina, et al.
Publicado: (2023)

Gut-Flora-Dependent Metabolite Trimethylamine-N-Oxide Promotes Atherosclerosis-Associated Inflammation Responses by Indirect ROS Stimulation and Signaling Involving AMPK and SIRT1
por: Zhou, Sa, et al.
Publicado: (2022)

Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome
por: Kong, Wanwen, et al.
Publicado: (2022)

Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor
por: Lakshmi, G. B. V. S., et al.
Publicado: (2021)

Uncovering the trimethylamine-producing bacteria of the human gut microbiota
por: Rath, Silke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sr14c17ck3gjgkld3r1faprv93